Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant718 active trials4 approved drugs55 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01443065 | MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma(MEGA) | completed | Phase 2 | 162 | UNICANCEROTHER | 1 | Nov 17, 2020 | clinicaltrials |
| NCT04338438 | Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer | completed | Phase 2 | 37 | Beijing Friendship HospitalOTHER | 0 | Nov 10, 2020 |
| clinicaltrials |
| NCT02420691 | Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin | completed | Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 30, 2020 | clinicaltrials |
| NCT00983801 | Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric Cancer | completed | Phase 2 | 58 | R-PharmINDUSTRY | 5 | Oct 28, 2020 | clinicaltrials |
| NCT00003862 | Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer | completed | Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 1 | Oct 19, 2020 | clinicaltrials |
| NCT04539769 | Impact of the Type of Reconstruction Methods on Diabetes Following Laparoscopic Distal Gastrectomy in Patients With Gastric Cancer and Type 2 Diabetes | completed | Phase 2 | 20 | Kyungpook National University Chilgok HospitalOTHER | 1 | Sep 7, 2020 | clinicaltrials |
| NCT01928290 | Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer(FOLFIRINOX) | completed | Phase 2 | 67 | Washington University School of MedicineOTHER | 1 | Aug 25, 2020 | clinicaltrials |
| NCT02581462 | FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer(PETRARCA) | completed | Phase 2 / Phase 3 | 81 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | Aug 11, 2020 | clinicaltrials |
| NCT00985192 | Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer | completed | Phase 2 | 49 | Translational Oncology Research InternationalOTHER | 1 | Aug 5, 2020 | clinicaltrials |
| NCT00003748 | Irinotecan in Treating Patients With Esophageal or Stomach Cancer | completed | Phase 2 | 40 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT00020761 | Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach | completed | Phase 2 | 51 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT02443883 | A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Junction (GEJ) Cancer | completed | Phase 2 | 164 | Eli Lilly and CompanyINDUSTRY | 12 | Jun 29, 2020 | clinicaltrials |
| NCT02514551 | A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer | completed | Phase 2 | 245 | Eli Lilly and CompanyINDUSTRY | 11 | Jun 17, 2020 | clinicaltrials |
| NCT01913639 | FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer | completed | Phase 2 | 39 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 15, 2020 | clinicaltrials |
| NCT02528110 | Radical Gastrectomy and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer | completed | Phase 2 | 100 | Wuhan UniversityOTHER | 1 | Mar 24, 2020 | clinicaltrials |
| NCT03606928 | mFLOT Chemotherapy as First-line Treatment in GC | completed | Phase 1 / Phase 2 | 18 | Ruijin HospitalOTHER | 1 | Mar 20, 2020 | clinicaltrials |
| NCT00439608 | Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer | completed | Phase 2 | 60 | Brown UniversityOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT02415023 | A Phase Ib/2 Clinical Study of Fruquintinib Combined With Paclitaxel in the Treatment of Advanced Gastric Cancer | completed | Phase 1 / Phase 2 | 34 | Hutchison Medipharma LimitedINDUSTRY | 1 | Feb 17, 2020 | clinicaltrials |
| NCT01516944 | Perioperative Chemotherapy for Potentially Resectable Gastric Cancer | completed | Phase 2 / Phase 3 | 749 | Hebei Medical UniversityOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT00525785 | Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) | completed | Phase 2 | 58 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 10, 2020 | clinicaltrials |
| NCT01747551 | FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer | completed | Phase 2 | 64 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 10, 2020 | clinicaltrials |
| NCT00565370 | Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XP | completed | Phase 1 / Phase 2 | 22 | Asan Medical CenterOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT00398398 | Study of XELOX With Cetuximab in Advanced Gastric Cancer | completed | Phase 2 | 44 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT00729482 | RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line Treatment | completed | Phase 2 | 54 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT00976768 | Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin | completed | Phase 2 | 44 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT01045538 | Study of Vorinostat Plus Capecitabine (X) and Cisplatin (P) for 1st Line Treatment of Metastatic or Recurrent Gastric Cancer: Zolinza+XP | completed | Phase 1 / Phase 2 | 45 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT01187212 | Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE | completed | Phase 2 | 195 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT01471470 | Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer | completed | Phase 2 | 31 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT01482299 | RAD001 in Advanced Gastric Cancer Who Failed Standard First-line Treatment With pS6 Ser 240/4 Expression | completed | Phase 2 | 45 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT01719549 | Dovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1 | completed | Phase 2 | 19 | Asan Medical CenterOTHER | 1 | Jan 7, 2020 | clinicaltrials |
| NCT02451956 | Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy | completed | Phase 2 | 21 | Samsung Medical CenterOTHER | 1 | Dec 30, 2019 | clinicaltrials |
| NCT00515411 | Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma | completed | Phase 2 | 111 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 10, 2019 | clinicaltrials |
| NCT02204306 | Genotype Guided Chemotherapy in Gastric Cancer Patients | completed | Phase 2 | 330 | Central South UniversityOTHER | 1 | Nov 18, 2019 | clinicaltrials |
| NCT01498289 | S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer | completed | Phase 2 | 213 | SWOG Cancer Research NetworkNETWORK | 1 | Nov 7, 2019 | clinicaltrials |
| NCT02406170 | Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma(REPEAT) | completed | Phase 1 / Phase 2 | 47 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Oct 22, 2019 | clinicaltrials |
| NCT02301481 | A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma | completed | Phase 2 | 71 | Chinese Academy of Medical SciencesOTHER | 1 | Oct 16, 2019 | clinicaltrials |
| NCT01983878 | A Study of Ramucirumab in Treating Japanese Participants With Metastatic Gastric or Gastroesophageal Junction Cancer | completed | Phase 2 | 36 | Eli Lilly and CompanyINDUSTRY | 1 | Sep 30, 2019 | clinicaltrials |
| NCT01059643 | A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 103 | Eli Lilly and CompanyINDUSTRY | 1 | Sep 18, 2019 | clinicaltrials |
| NCT01743365 | Clinical Trial of Chemotherapy Combination Cisplatin-Fluorouracil-Afatinib in Patients With Inoperable Gastric Cancer(A-GAPP) | completed | Phase 2 | 55 | Hellenic Cooperative Oncology GroupOTHER | 1 | Sep 4, 2019 | clinicaltrials |
| NCT02999295 | A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer | completed | Phase 1 / Phase 2 | 46 | National Cancer Center, JapanOTHER_GOV | 1 | Aug 21, 2019 | clinicaltrials |
| NCT00414271 | Neo-adjuvant Chemotherapy in Locally Advanced Gastric Cancer | completed | Phase 2 | 18 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jul 25, 2019 | clinicaltrials |
| NCT01216644 | 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer | completed | Phase 2 / Phase 3 | 716 | Krankenhaus NordwestOTHER | 1 | Jun 19, 2019 | clinicaltrials |
| NCT01132755 | Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage | completed | Phase 2 | 112 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 14, 2019 | clinicaltrials |
| NCT00601705 | Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach | completed | Phase 2 | 61 | Case Comprehensive Cancer CenterOTHER | 1 | Apr 30, 2019 | clinicaltrials |
| NCT01514110 | Gastric Cancer RAD001 Study | completed | Phase 1 / Phase 2 | 35 | Chinese University of Hong KongOTHER | 1 | Apr 2, 2019 | clinicaltrials |
| NCT00217581 | Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer | completed | Phase 2 | 39 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Mar 26, 2019 | clinicaltrials |
| NCT01715233 | Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer. | completed | Phase 2 | 27 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 15, 2019 | clinicaltrials |
| NCT00711243 | Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor | completed | Phase 1 / Phase 2 | 59 | Northwestern UniversityOTHER | 1 | Feb 26, 2019 | clinicaltrials |
| NCT01129310 | First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.(IXOGoo1) | completed | Phase 2 | 47 | AHS Cancer Control AlbertaOTHER | 1 | Feb 25, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Nov 17, 2020source: clinicaltrials